
Santen Pharmaceutical Co Ltd
TSE:4536

Intrinsic Value
The intrinsic value of one
Santen Pharmaceutical Co Ltd
stock under the Base Case scenario is
2 147.18
JPY.
Compared to the current market price of 1 451 JPY,
Santen Pharmaceutical Co Ltd
is
Undervalued by 32%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Santen Pharmaceutical Co Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Santen Pharmaceutical Co Ltd
Balance Sheet Decomposition
Santen Pharmaceutical Co Ltd
Current Assets | 205.1B |
Cash & Short-Term Investments | 78.7B |
Receivables | 69.3B |
Other Current Assets | 57.2B |
Non-Current Assets | 193.2B |
Long-Term Investments | 20.2B |
PP&E | 74.4B |
Intangibles | 79.6B |
Other Non-Current Assets | 19B |
Free Cash Flow Analysis
Santen Pharmaceutical Co Ltd
JPY | |
Free Cash Flow | JPY |
Earnings Waterfall
Santen Pharmaceutical Co Ltd
Revenue
|
301.9B
JPY
|
Cost of Revenue
|
-129.3B
JPY
|
Gross Profit
|
172.6B
JPY
|
Operating Expenses
|
-135B
JPY
|
Operating Income
|
37.6B
JPY
|
Other Expenses
|
-10.1B
JPY
|
Net Income
|
27.5B
JPY
|
Profitability Score
Profitability Due Diligence
Santen Pharmaceutical Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Score
Santen Pharmaceutical Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Santen Pharmaceutical Co Ltd's solvency score is 91/100. The higher the solvency score, the more solvent the company is.

Score
Santen Pharmaceutical Co Ltd's solvency score is 91/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Santen Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
Santen Pharmaceutical Co Ltd
is 2 061.53 JPY
with a low forecast of 1 717 JPY and a high forecast of 2 625 JPY.
Dividends
Current shareholder yield for Santen Pharmaceutical Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Santen Pharmaceutical Co Ltd
stock under the Base Case scenario is
2 147.18
JPY.
Compared to the current market price of 1 451 JPY,
Santen Pharmaceutical Co Ltd
is
Undervalued by 32%.